Belvedere Trading
AMPH icon

Belvedere Trading’s Amphastar Pharmaceuticals AMPH Stock Holding History

Belvedere Trading’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,867
Closed -$268K – 357
2022
Q1 		$268K Buy
+6,867
New +$195K 0.01% 196

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Belvedere Trading's AMPH Position: Q2 2022 in Review

Belvedere Trading sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2022, closing a stake of 6,867 shares — an estimated $268K sold.

Belvedere Trading first reported a position in AMPH in Q1 2022 and held it in 1 quarter. The position peaked at $268K in Q1 2022. 223 funds tracked by Wall St. Rank hold AMPH as of Q2 2022.

  • Belvedere Trading reported no remaining Amphastar Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Belvedere Trading sold 6,867 Amphastar Pharmaceuticals shares in Q2 2022, an estimated $268K.
  • Belvedere Trading first reported a position in Amphastar Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • Belvedere Trading's Amphastar Pharmaceuticals position peaked at $268K in Q1 2022.
  • 223 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2022.

Based on Belvedere Trading's 13F filing for Q2 2022, filed 21 Jul 2022.